Federal decision makers need access to the best available science in order to craft policies that protect our health, safety, and environment.
Unfortunately, censorship of scientists and the manipulation, distortion, and suppression of scientific information have threatened federal science in recent years.
This problem has sparked much debate, but few have identified the key driver of political interference in federal science: the inappropriate influence of companies with a financial stake in the outcome.
A new UCS report, Heads They Win, Tails We Lose, shows how corporations influence the use of science in federal decision making to serve their own interests.
Methods of abuse
The report describes five basic methods that corporations use to influence the scientific and policy-making processes:
Corrupting the science. Corporations suppress research, intimidate scientists, manipulate study designs, ghostwrite scientific articles, and selectively publish results that suit their interests.
Shaping public perception. Private interests downplay evidence, exaggerate uncertainty, vilify scientists, hide behind front groups, and feed the media slanted news stories.
Restricting agency effectiveness. Companies attack the science behind agency policy, hinder the regulatory process, corrupt advisory panels, exploit the "revolving door" between corporate and government employment, censor scientists, and withhold information from the public.
Influencing congress. By spending billions of dollars on lobbying and campaign contributions, corporate interests gain undue access to members of Congress, encouraging them to challenge scientific consensus, delay action on critical problems, and shape the use of science in policy making.
Exploiting judicial pathways. Corporate interests have expanded their influence on the judicial system, used the courts to undermine science, and exploited judicial processes to bully and silence scientists.
How do they game the system? Let us recount the ways
Heads They Win, Tails We Lose is full of real-world examples of the ways corporations interfere with science. Here are just a few of the highlights:
Suppressing research: hog farm emissions
After pork producers contacted his supervisors, a USDA microbiologist was prevented from publishing research showing that emissions from industrial hog farms contained antibiotic-resistant bacteria.
Corrupting advisory panels: childhood lead poisoning
A few weeks before a CDC advisory panel met to discuss revising federal lead standards, two scientists with ties to the lead industry were added to the panel. The committee voted against tightening the standards.
Ghostwriting articles: the pharmaceutical industry
A 2011 analysis found evidence of corporate authorship in research articles on a variety of drugs, including Avandia, Paxil, Tylenol, and Vioxx.
For more examples, see our Disinformation Playbook.
Progress made (and still to be made)
In his 2009 inaugural address, President Obama promised to "restore science to its rightful place." His administration has made progress toward that goal on several important fronts—elevating the role of science in government, ordering agencies to develop scientific integrity policies, improving transparency, and strengthening conflict-of-interest policies.
Despite these positive steps, much remains to be done. The report identifies five key areas where further federal commitments to protect science from undue corporate influence are needed: protecting government scientists from retaliation and intimidation; making government more transparent and accountable; reforming the regulatory process; strengthening scientific advice to government; and strengthening monitoring and enforcement.
Corporations, nonprofits, academic institutions, scientific societies, and the media also have critical roles to play in reducing abuses of science in federal decision making. These institutions should:
- promote honest scientific investigation and open discussion of research results;
- refrain from actual or perceived acts of scientific misconduct;
- embrace transparency and avoid conflicts of interest.
Inappropriate corporate interference in science extends its tentacles into every aspect of federal science-based policy-making. Addressing this interference will require overcoming high hurdles, but they are not insurmountable. With strong leadership and a sustained commitment, both the federal government and the private sector can rise to the challenge.